Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Case Report of Advanced Childhood Nasopharyngeal Carcinoma: Is Radiotherapy Dose Deescalation the Right Way in Good Responders to Induction Chemotherapy

E. Encheva, Hr. Ivanovska, G. Iliev, P. Bochev, B. Chaushev, Ts. Yordanova, R. Georgiev, V. Kaleva, Hr. Hristozova, M. Milkov

Abstract

Objectives:. Treatment of childhood NPC similar to adults consists of radiotherapy and chemotherapy, but distant failure is often observed, which led to introducing the induction chemotherapy followed by radiation or chemoradiation. The improved survival rates raised the question of late toxicity. The options for lowering the toxicity rate is the application of advanced radiotherapy techniques like IMRT and VMAT, and deescalation of the radiation dose in good responders and early NPC.
Case report: We report a case of13-years old male patient with a high-risk childhood undifferentiated NPC, stage cT4 cN2b M0. He presented with unilateral swallowing at the middle third of left muscle sterenocleidomastoideus, and headache, fever, sore throat and intermittent nasal bleeding for an year. Diagnostic MRI and PET/CT showed good concordance for primary tumor extension and lymph node involvement. Three coursesinduction chemotherapy were applied according to NPC2003-GPOH protocolwith good treatment response. The restaging PET/CT found no distant metastasis. Deescalated protocol of radiotherapy alone was delivered to 50.4 Gy total dose with IGRT, VMAT irradiation technique. At three month PET/CT follow up a solitary bone lesion was detected.
Conclusion: The present case proved that in high risk patients more aggressive treatment strategies should be recommended with no omission of concurrent chemotherapy even after full response. Deescalation of radiotherapy dose probably is not appropriate in this group of patients. MRI and PET CT should be used as complementary imaging modalities for early detection of locoregional or distant metastasis.

Keywords

Childhood nasopharyngeal carcinoma, treatment, radiotherapy, deescalation radiation dose, VMAT

Full Text


References

Ayan I, Altun M. Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys. 1996;35:485–492.

Valerianova Z, Atanasov T, Vukov M. et al. Cancer Incidence in Bulgaria, 2014 & 2015. Bulgarian National Cancer Registry. Sofia, 2017

Dourthe ME, Bolle S, Temam S, Jouin A, Claude L, Reguerre Y, Defachelles AS, Orbach D, Fresneau B. Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future. J Pediatr Hematol Oncol. 2018 Mar;40(2):85-92

Mertens R, Granzen B, Lassay L, et al. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-German Society of Pediatric Oncology and Hematology ). Cancer 2005;104:1083–1089.

Rodriguez–Galindo C, Wofford M, Castleberry RP, et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 2005;103:850–857

Buehrlen M, Zwaan CM, Granzen B, et al. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. Cancer. 2012;118:4892–4900

Kontny U, Franzen S, Behrends U, et al. Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents—recommendations of the GPOH-NPC study group. Klin Padiatr. 2016;228:105–112

Cheuk DKL, Sabin ND, Hossain M, et al. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2012;39:1097–1106

Guo Q, Cui X, Lin S, Lin J, Pan J Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy.Head Neck. 2016 Apr;38 Suppl 1:E665-72.




DOI: http://dx.doi.org/10.14748/orl.v14i2.6770

Refbacks

Font Size


|